Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 22 of 22 entries
Sorted by: Best Match Show Resources per page
Quality of life in thyroid cancer patients: a literature review.

Clujul medical (1957)

Bãrbuş E, Peştean C, Larg MI, Piciu D.
PMID: 28559697
Clujul Med. 2017;90(2):147-153. doi: 10.15386/cjmed-703. Epub 2017 Apr 25.

INTRODUCTION: Quality of life (QoL) has received increasing interest in the last years, especially in patients with cancer. This article aims to analyze a selection of medical research papers regarding the quality of life in patients with thyroid carcinoma....

Comparison of I-131 Biokinetics after Recombinant Human TSH Stimulation and Thyroid Hormone Withdrawal Measured by External Detector in Patients with Differentiated Thyroid Cancer.

Chonnam medical journal

Kairemo K, Kangasmäki A, Bom HS.
PMID: 30740336
Chonnam Med J. 2019 Jan;55(1):20-24. doi: 10.4068/cmj.2019.55.1.20. Epub 2019 Jan 25.

The aim of this study was to compare radioactive iodine (I-131) biokinetics after recombinant human TSH stimulation (rhTSH) and thyroid hormone withdrawal (THW) in patients with differentiated thyroid cancer (DTC). External effective dose rates were measured using external detectors...

I-131 Radiation-Induced Myelosuppression in Differentiated Thyroid Cancer Therapy.

Molecular imaging and radionuclide therapy

Probst S, Abikhzer G, Chaussé G, Tamilia M.
PMID: 29889031
Mol Imaging Radionucl Ther. 2018 Jun 07;27(2):84-87. doi: 10.4274/mirt.59454.

Radioactive iodine (RAI) treatment of differentiated thyroid cancer has been used in clinical practice for almost 60 years and is generally accepted to be a safe and efficacious treatment. Severe toxicity in the form of radiation pneumonitis, sometimes progressing...

Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer.

Chonnam medical journal

Mu ZZ, Zhang X, Lin YS.
PMID: 31598469
Chonnam Med J. 2019 Sep;55(3):127-135. doi: 10.4068/cmj.2019.55.3.127. Epub 2019 Sep 24.

Most differentiated thyroid cancer (DTC) patients have an excellent prognosis. However, about one-third of DTC patients with recurrent or metastatic disease lose the hallmark of specific iodine uptake initially or gradually and acquire radioactive iodine-refractory DTC (RAIR-DTC) with poor...

CT-guided .

Experimental and therapeutic medicine

Yang B, Guo WH, Lan T, Yuan F, Liu GJ, Zan RY, You X, Tan QY, Liao ZY.
PMID: 28101168
Exp Ther Med. 2016 Dec;12(6):3843-3850. doi: 10.3892/etm.2016.3897. Epub 2016 Nov 14.

Radical surgery is currently the first treatment of choice for retroperitoneal soft tissue sarcoma (RSTS). However, the prognosis of RSTS remains poor due to ineffective local control and a high incidence of metastasis after surgical resection. Brachytherapy has been...

Clinical observation of (125)I-labeled anti-alpha fetoprotein antibody radioimmunotherapy in hepatocellular carcinoma.

World journal of gastroenterology

Wu YD, Yang KZ, Zhou DN, Gang YQ, Song XQ, Hu XH, Huang BY.
PMID: 27006585
World J Gastroenterol. 1997 Mar 15;3(1):43-6. doi: 10.3748/wjg.v3.i1.43.

AIM: To observe the therapeutic effects and toxic side effects of (125)I labeled horse anti-human alpha fetoprotein (AFP) polyclonal antibodies in immune targeted therapy against hepatocellular carcinoma (HCC).METHODS: A modified chloramine-T method to produce nuclide (125)I labeled horse anti-human...

Relationship between two year PSA nadir and biochemical recurrence in prostate cancer patients treated with iodine-125 brachytherap.

Radiologia brasileira

Franca CA, Vieira SL, Carvalho AC, Bernabe AJ, Penna AB.
PMID: 25741055
Radiol Bras. 2014 Mar-Apr;47(2):89-93. doi: 10.1590/S0100-39842014000200010.

OBJECTIVE: To evaluate the relationship between two year PSA nadir (PSAn) after brachytherapy and biochemical recurrence rates in prostate cancer patients.MATERIALS AND METHODS: In the period from January 1998 to August 2007, 120 patients were treated with iodine-125 brachytherapy...

Mechanisms of regulating NIS transport to the cell membrane and redifferentiation therapy in thyroid cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Cai X, Wang R, Tan J, Meng Z, Li N.
PMID: 34100218
Clin Transl Oncol. 2021 Dec;23(12):2403-2414. doi: 10.1007/s12094-021-02655-0. Epub 2021 Jun 08.

Iodine is an essential constituent of thyroid hormone. Active iodide accumulation in the thyroid is mediated by the sodium iodide symporter (NIS), comprising the first step in thyroid hormone biosynthesis, which relies on the functional expression of NIS on...

Thyroid storm following radioactive iodine (RAI) therapy for pediatric graves disease.

The American journal of case reports

Rohrs HJ, Silverstein JH, Weinstein DA, Amdur RJ, Haller MJ.
PMID: 24847412
Am J Case Rep. 2014 May 14;15:212-5. doi: 10.12659/AJCR.890366. eCollection 2014.

PATIENT: Female, 11 FINAL DIAGNOSIS: Thyroid storm Symptoms: Diarrhea • tachycardia • tachypnea • tremor • wheezingMEDICATION: - Clinical Procedure: - Specialty: -OBJECTIVE: Rare disease.BACKGROUND: A growing number of pediatric endocrinologists treat Graves disease with radioactive iodine (RAI) therapy...

Serial stimulated thyroglobulin measurements are more specific for detecting distant metastatic differentiated thyroid cancer before radioiodine therapy.

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Zhao T, Liang J, Li T, Gao W, Lin Y.
PMID: 28729772
Chin J Cancer Res. 2017 Jun;29(3):213-222. doi: 10.21147/j.issn.1000-9604.2017.03.07.

OBJECTIVE: Preablative stimulated thyroglobulin (ps-Tg) has the potential to be used in identifying distant metastatic differentiated thyroid carcinoma (DM-DTC), but its single level can be affected by remnant thyroid tissue and thyrotropin (TSH). The objective of this retrospective study...

Showing 25 to 22 of 22 entries